Bioventus: Barrington Research raises PT to $14 from $13, maintains Outperform rating

viernes, 6 de marzo de 2026, 2:01 pm ET1 min de lectura
BVS--

Bioventus: Barrington Research raises PT to $14 from $13, maintains Outperform rating

Bioventus: Barrington Research raises PT to $14 from $13, maintains Outperform rating

Comentarios



Add a public comment...
Sin comentarios

Aún no hay comentarios